FLRT2 and neoplasm: Similar to the transient effect of VEGF blockade during the ‘‘normalization window’’ (26, 27), deletion of endothelial Flrt2 increased the tumor-suppressing effects of a cytotoxic agent, cisplatin (28, 29), and those of immunotherapeutic drugs (anti-PD1 antibodies) (Figure 3).